A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...

funding to further develop a prophylactic vaccine based on its proprietary outer membrane vesicles (OMV) platform technology. Called NGoXIM, the vaccine is based on gonococcal OMVs combined with ...

In preclinical studies using mice with advanced colorectal cancer and melanoma (skin cancer), the bacterial vaccine was able to boost the immune system enough to suppress tumor growth, and in many ...

Two preclinical studies, published Jan. 10 in Nature Microbiology, tackle the challenge of engineering bacteria that are safe for use in controlled human infection trials or as better vaccines.

A painless future of vaccination could be on the horizon ... Family Professor and a professor of bioengineering. Some bacteria, like harmless Staphylococcus epidermidis, have adapted to thrive ...

Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate ...